Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers - Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology0 个研究点目标入组 35 人开始时间: 2015年5月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Persons who have received NSAIDs within 3 months before obtaining the consent (excluding topical administration of NSAIDs) 2)Persons with history of food or drug allergy (diclofenac sodium, lubiprostone, etc.) or who are suspected of such allergy 3)Persons with current or history of serious cardiovascular/vascular, hematological, respiratory, liver, kidney, gastrointestinal, or neuropsychiatric disease 4)Persons who are taking proton pump inhibitors (PPIs), antibiotics, or intestinal drugs (excluding topical administration of antibiotics) 5)Persons who have participated in other clinical studies and received the study drug, etc. within 1 month prior to the start of this study (calculated from the administration date of the study drug) 6)Persons who were judged by the investigator, etc. to be inappropriate as a subject for this study

发起方

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology